VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TCMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TCMDTactile Systems Technology, Inc.
$26.03$587M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTCMDCash Flow

Tactile Systems Technology, Inc. (TCMD) Cash Flow Statement

13Y historyFree accessUpdated daily

Operating cash flow of $12.0M in 2026Q3 translated into 1.67 times net income, yet quarterly conversion ranged from -0.14 to 4.59 times and working capital swung by as much as $16.5M, suggesting reported cash strength may reflect timing effects rather than durable earnings quality.

Income StatementBalance SheetCash FlowRatios

TCMD Cash Flow Statement

Annual statement

TCMD Cash Flow Statement

Tactile Systems Technology, Inc. (TCMD) cash flow statement — 13-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Cash from Operations32.19M42.81M40.66M35.85M5.21M2.63M2.79M2.51M9.01M4.19M7.03M1.36M-991K-425K
Operating CF Margin %-12.99%13.88%13.07%2.11%1.26%1.49%1.32%6.27%3.84%8.32%2.16%-2.08%-1.14%
Operating CF Growth %-237.52%5.3%13.39%588.33%97.99%-5.83%11.31%-72.13%114.86%-40.4%417.89%237.03%-133.18%-
Net Income23.82M19.09M16.96M28.52M-17.87M-11.81M-620K10.97M6.62M5.86M2.88M1.39M2.07M3.16M
Depreciation & Amortization6.84M6.64M6.8M6.5M6.27M3.7M2.79M3.54M3.63M1.85M799K827K706K585K
Stock-Based Compensation8.95M8.36M7.82M7.55M9.6M10.17M10.69M9.82M7.97M4.24M1.89M316K148K132K
Deferred Taxes7.01M8.53M1.07M-19.38M-32K10.23M-1.23M-146K-6.18M143K-611K852K1.56M-941K
Other Non-Cash Items-2.48M78K300K-2.43M11.87M-199K3.92M848K2.54M301K568K94K500K325K
Working Capital Changes-11.96M119K7.71M15.1M-4.63M-9.46M-12.76M-22.52M-5.58M-8.19M1.51M-2.12M-5.97M-3.68M
Change in Receivables-11.03M-153K9.17M23.78M-15.56M-9.04M-15.65M-11.41M-5.88M-3.59M-2.2M-1.25M-5.05M-4.33M
Change in Inventory488K4.64M3.86M597K-3.91M972K318K-7.87M-870K-4.49M-773K-2.26M-608K-884K
Change in Payables3.9M-758K-1.09M-3.85M4.96M826K337K-1.39M690K462K1.74M829K547K476K
Cash from Investing-12.56M-2.54M-2.5M-2.48M-1.91M-82.18M20.18M-2.33M-14.73M-14.02M-11.84M-615K-353K-364K
Capital Expenditures-3.17M-2.38M-2.39M-2.32M-1.78M-2.1M-2.06M-5.45M-9.55M-3.82M-833K-615K-353K-364K
CapEx % of Revenue0.89%0.72%0.82%0.85%0.72%1.01%1.1%2.87%6.64%3.5%0.99%0.98%0.74%0.98%
Acquisitions-6.23M0000-79.83M005.35M-74K0000
Investments--------------
Other Investing-3.17M-155K-105K-157K-129K-252K-262K-542K-5.85M-71K-11.07M-23K00
Cash from Financing-10.49M-51.2M-4.82M5.73M-9.6M59.93M2.11M2.5M1.85M3.09M28.45M901K221K-2.08M
Debt Issued (Net)0-26.25M-3M-19.75M-6M54.81M00000-392K-9K-32K
Equity Issued (Net)-10.49M-24.95M-3.51M34.63M06.29M000-493K36.66M914K0-105K
Dividends Paid0000000000-8.21M000
Share Repurchases-12.53M-26.56M-3.51M00000-2.38M-493K000-105K
Other Financing001.68M-9.14M-3.6M-1.17M2.11M2.5M1.85M3.58M00230K-1.94M
Net Change in Cash9.14M-10.92M33.33M39.1M-6.3M-19.63M25.09M2.67M-3.87M-6.73M23.64M1.64M-1.12M-2.86M
Free Cash Flow28.96M40.43M38.15M33.37M3.29M276K503K-3.48M-539K372K6.2M743K-1.34M-789K
FCF Margin %8.12%12.27%13.02%12.16%1.33%0.13%0.27%-1.84%-0.38%0.34%7.33%1.18%-2.82%-2.12%
FCF Growth %-26.5%5.99%14.3%914.72%1091.67%-45.13%114.46%-545.27%-244.89%-94%734.45%155.28%-70.34%-
FCF per Share1.261.741.581.440.160.010.03-0.18-0.030.020.370.06-0.10-0.33
FCF Conversion (FCF/Net Income)1.22x2.24x2.40x1.26x-0.29x-0.22x-4.51x0.23x1.36x0.72x2.44x0.97x-0.48x-0.13x
Interest Paid462K1.22M2.11M4.56M2.19M130K00-9K001K1K6K
Taxes Paid6.85M2.5M6.85M5.82M44K1.59M543K344K-2.88M923K2.16M240K238K117K

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Volatile quarterly cash conversion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Cash Conversion Swings With Quarterly Earnings

Based on reported quarterly figures, TCMD's operating cash flow to net income ratio ranged from negative 0.14 to 4.59 across ten quarters, indicating that reported earnings are a poor short-term guide to cash generation.

The ratio exceeding 1.5 in most profitable quarters suggests that non-cash charges and working capital releases frequently lift operating cash flow above reported income. The negative reading in 2025Q1, where net income was a loss and operating cash flow was near zero, shows the conversion relationship breaks down when earnings are weak. Investors should monitor whether the favorable conversion persists once working capital normalizes, since recent quarters appear to rely heavily on timing effects rather than structurally higher earnings quality.

Free Cash Flow Margins Remain Uneven

As reported in the quarterly statements, TCMD's free cash flow margin peaked at 18.5% in 2024Q4 and 18.2% in 2025Q2, before falling to 2.3% in 2026Q2 and turning negative at -1.6% in 2026Q1.

The trajectory indicates that free cash flow has been episodic rather than compounding, with the strongest quarters clustered around the fourth quarter and mid-year periods. The 12.4% margin in 2026Q3 reflects a sharp rebound, but a single quarter does not establish a durable trend given the prior volatility. Given the thin trailing operating margin, the free cash flow profile appears more dependent on working capital movements than on the underlying business economics.

Asset-Light Model With Minimal Reinvestment

Based on reported figures, TCMD's capital expenditures consistently ran between 0.5% and 1.5% of revenue, reflecting an asset-light model that requires little physical reinvestment to sustain operations.

The low capital intensity is consistent with a business whose primary cost base is labor-driven sales and clinical support rather than manufacturing infrastructure. Depreciation and amortization of roughly $1.6M to $2.5M per quarter exceeds capital spending in most periods, which may suggest that the asset base is being run down slightly or that capitalized items are being recognized in D&A. Investors should monitor whether this minimal reinvestment is sufficient to support the planned respiratory product expansion.

Working Capital Drives Cash Timing

According to the quarterly cash flow data, working capital changes ranged from a $16.5M absorption to an $8.2M release, indicating that receivables and payables timing materially shifts reported cash flow from period to period.

The swings appear consistent with the reimbursement cycle described in the revenue structure, where insurance authorization delays can defer cash collection after device delivery. The large working capital release in 2025Q2 coincided with a sharp decline in buybacks, which may suggest the company used collected receivables to fund repurchases. Investors should watch receivable aging and the provision for doubtful accounts, as persistent working capital absorption would weaken the conversion story.

Buybacks Absorb Cash Without Dividends

As reported in the cash flow statements, TCMD paid no dividends across the period while repurchasing shares for amounts including $16.5M in 2025Q2 and $10.0M in 2025Q1, consuming a large share of free cash flow.

Repurchases appear to be the primary channel for capital return, and their timing has been opportunistic, clustering in quarters following stronger cash generation. Given the company's near-zero debt and cash position above $83M, the buyback pace suggests management is comfortable deploying surplus liquidity. Investors should assess whether repurchases continue at this pace if free cash flow remains volatile, as sustained buybacks against weak quarters could erode the balance sheet cushion.

Reported Cash Strength May Overstate Durability

Based on reported figures, the 2026Q3 cash conversion spike to 1.67 times net income may reflect timing effects rather than durable earnings quality, given the volatile prior-period working capital swings.

Stock-based compensation of roughly $1.8M to $2.5M per quarter is added back in operating cash flow, which may flatter conversion relative to a cash-based cost view. The recent rebound from negative free cash flow in 2026Q1 to 12.4% in 2026Q3 rests on a single quarter that coincided with an EPS miss, so investors should verify whether working capital release reverses in subsequent periods before treating it as a trend.

TCMD — Frequently Asked Questions

Quick answers to the most common questions about buying TCMD stock.

How much cash does Tactile Systems Technology, Inc. (TCMD) generate from operations?

Tactile Systems Technology, Inc. (TCMD) generated $42.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Tactile Systems Technology, Inc.'s free cash flow?

Tactile Systems Technology, Inc. (TCMD) generated $40.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Tactile Systems Technology, Inc.'s capital expenditure (CapEx)?

Tactile Systems Technology, Inc. (TCMD) spent $2.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Tactile Systems Technology, Inc. distribute cash to shareholders?

In 2025, Tactile Systems Technology, Inc. (TCMD) spent $26.6M on share repurchases. This shows the company's commitment to returning capital to its equity investors.